Advertisement
Screener

10x Genomics, Inc. (TXG) Increase (Decrease) in Employee Related Liabilities

10x Genomics, Inc. Increase (Decrease) in Employee Related Liabilities

10x Genomics, Inc. (TXG) reported Increase (Decrease) in Employee Related Liabilities of -$17.83 million for the 6-month period ending 2026-06-30, per its 10-Q filed 2026-08-07.

Financial Statements › Cash Flow › Operating Activities

us-gaap:IncreaseDecreaseInEmployeeRelatedLiabilities · last filed 2026-08-07

  • 10x Genomics, Inc. increase (decrease) in employee related liabilities for the quarter ending 2026-06-30 was $3.12M, a 20.49% decline year-over-year.
  • 10x Genomics, Inc. increase (decrease) in employee related liabilities for the quarter ending 2026-03-31 was -$20.96M.
  • 10x Genomics, Inc. increase (decrease) in employee related liabilities for the quarter ending 2025-12-31 was $5.36M, a 43.82% increase year-over-year.
  • 10x Genomics, Inc. increase (decrease) in employee related liabilities for the quarter ending 2025-09-30 was $10.10M, a 2.19% increase year-over-year.
  • 10x Genomics, Inc. increase (decrease) in employee related liabilities for fiscal 2025 was $7.65M, a 109.28% increase from fiscal 2024.
  • 10x Genomics, Inc. increase (decrease) in employee related liabilities for fiscal 2024 was $3.65M.
  • 10x Genomics, Inc. increase (decrease) in employee related liabilities for fiscal 2023 was -$2.64M, a 336.71% decline from fiscal 2022.
  • 10x Genomics, Inc. increase (decrease) in employee related liabilities for fiscal 2022 was $1.11M, a 93.18% decline from fiscal 2021.
Period endIncrease (Decrease) in Employee Related Liabilities 3 monthIncrease (Decrease) in Employee Related Liabilities 6 monthIncrease (Decrease) in Employee Related Liabilities 9 monthIncrease (Decrease) in Employee Related Liabilities 12 month
2026-06-30$3.12M
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-07
-$17.83M
10-Q · filed 2026-08-07
-$12.47M
derived: sum of 3 quarters · filed 2026-08-07
-$2.37M
derived: sum of 4 quarters · filed 2026-08-07
2026-03-31-$20.96M
10-Q · filed 2026-05-08
-$15.59M
derived: sum of 2 quarters · filed 2026-05-08
-$5.49M
derived: sum of 3 quarters · filed 2026-05-08
-$1.56M
derived: sum of 4 quarters · filed 2026-08-07
2025-12-31$5.36M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-13
$15.46M
derived: sum of 2 quarters · filed 2026-02-13
$19.39M
derived: sum of 3 quarters · filed 2026-08-07
$7.65M
10-K · filed 2026-02-13
2025-09-30$10.10M
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-07
$14.03M
derived: sum of 2 quarters · filed 2026-08-07
$2.28M
10-Q · filed 2025-11-07
$6.01M
derived: sum of 4 quarters · filed 2026-08-07
2025-06-30$3.93M
derived: 10-Q 6 month − 10-Q 3 month · filed 2026-08-07
-$7.82M
10-Q · filed 2026-08-07
-$4.09M
derived: sum of 3 quarters · filed 2026-08-07
$5.80M
derived: sum of 4 quarters · filed 2026-08-07
2025-03-31-$11.74M
10-Q · filed 2026-05-08
-$8.02M
derived: sum of 2 quarters · filed 2026-05-08
$1.87M
derived: sum of 3 quarters · filed 2026-05-08
$1.29M
derived: sum of 4 quarters · filed 2026-05-08
2024-12-31$3.73M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-13
$13.61M
derived: sum of 2 quarters · filed 2026-02-13
$13.03M
derived: sum of 3 quarters · filed 2026-02-13
$3.65M
10-K · filed 2026-02-13
2024-09-30$9.88M
derived: 10-Q 9 month − 10-Q 6 month · filed 2025-11-07
$9.30M
derived: sum of 2 quarters · filed 2025-11-07
-$75.00K
10-Q · filed 2025-11-07
$1.46M
derived: sum of 4 quarters · filed 2026-02-13
2024-06-30-$580.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2025-08-08
-$9.96M
10-Q · filed 2025-08-08
-$8.43M
derived: sum of 3 quarters · filed 2026-02-13
-$2.28M
derived: sum of 4 quarters · filed 2026-02-13
2024-03-31-$9.38M
10-Q · filed 2025-05-09
-$7.85M
derived: sum of 2 quarters · filed 2026-02-13
-$1.70M
derived: sum of 3 quarters · filed 2026-02-13
$3.11M
derived: sum of 4 quarters · filed 2026-02-13
2023-12-31$1.53M
derived: 10-K 12 month − 10-Q 9 month · filed 2026-02-13
$7.68M
derived: sum of 2 quarters · filed 2026-02-13
$12.49M
derived: sum of 3 quarters · filed 2026-02-13
-$2.64M
10-K · filed 2026-02-13
2023-09-30$6.14M
derived: 10-Q 9 month − 10-Q 6 month · filed 2024-10-29
$10.96M
derived: sum of 2 quarters · filed 2024-10-29
-$4.17M
10-Q · filed 2024-10-29
$108.00K
derived: sum of 4 quarters · filed 2025-02-13
2023-06-30$4.82M
derived: 10-Q 6 month − 10-Q 3 month · filed 2024-08-08
-$10.31M
10-Q · filed 2024-08-08
-$6.04M
derived: sum of 3 quarters · filed 2025-02-13
-$1.19M
derived: sum of 4 quarters · filed 2025-02-13
2023-03-31-$15.13M
10-Q · filed 2024-04-30
-$10.85M
derived: sum of 2 quarters · filed 2025-02-13
-$6.01M
derived: sum of 3 quarters · filed 2025-02-13
-$732.00K
derived: sum of 4 quarters · filed 2025-02-13
2022-12-31$4.28M
derived: 10-K 12 month − 10-Q 9 month · filed 2025-02-13
$9.12M
derived: sum of 2 quarters · filed 2025-02-13
$14.40M
derived: sum of 3 quarters · filed 2025-02-13
$1.11M
10-K · filed 2025-02-13
2022-09-30$4.84M
derived: 10-Q 9 month − 10-Q 6 month · filed 2023-11-03
$10.12M
derived: sum of 2 quarters · filed 2023-11-03
-$3.16M
10-Q · filed 2023-11-03
$1.31M
derived: sum of 4 quarters · filed 2024-02-15
2022-06-30$5.28M
derived: 10-Q 6 month − 10-Q 3 month · filed 2023-08-04
-$8.01M
10-Q · filed 2023-08-04
-$3.54M
derived: sum of 3 quarters · filed 2024-02-15
$2.60M
derived: sum of 4 quarters · filed 2024-02-15
2022-03-31-$13.28M
10-Q · filed 2023-05-04
-$8.81M
derived: sum of 2 quarters · filed 2024-02-15
-$2.68M
derived: sum of 3 quarters · filed 2024-02-15
$1.75M
derived: sum of 4 quarters · filed 2024-02-15
2021-12-31$4.47M
derived: 10-K 12 month − 10-Q 9 month · filed 2024-02-15
$10.61M
derived: sum of 2 quarters · filed 2024-02-15
$15.04M
derived: sum of 3 quarters · filed 2024-02-15
$16.34M
10-K · filed 2024-02-15
2021-09-30$6.14M
derived: 10-Q 9 month − 10-Q 6 month · filed 2022-11-03
$10.57M
derived: sum of 2 quarters · filed 2022-11-03
$11.87M
10-Q · filed 2022-11-03
$16.09M
derived: sum of 4 quarters · filed 2023-02-16
2021-06-30$4.43M
derived: 10-Q 6 month − 10-Q 3 month · filed 2022-08-09
$5.73M
10-Q · filed 2022-08-09
$9.95M
derived: sum of 3 quarters · filed 2023-02-16
$10.76M
derived: sum of 4 quarters · filed 2023-02-16
2021-03-31$1.30M
10-Q · filed 2022-05-05
$5.52M
derived: sum of 2 quarters · filed 2023-02-16
$6.33M
derived: sum of 3 quarters · filed 2023-02-16
-$1.95M
derived: sum of 4 quarters · filed 2023-02-16
2020-12-31$4.22M
derived: 10-K 12 month − 10-Q 9 month · filed 2023-02-16
$5.03M
derived: sum of 2 quarters · filed 2023-02-16
-$3.25M
derived: sum of 3 quarters · filed 2023-02-16
$2.94M
10-K · filed 2023-02-16
2020-09-30$811.00K
derived: 10-Q 9 month − 10-Q 6 month · filed 2021-11-05
-$7.48M
derived: sum of 2 quarters · filed 2021-11-05
-$1.29M
10-Q · filed 2021-11-05
$3.17M
derived: sum of 4 quarters · filed 2022-02-18
2020-06-30-$8.29M
derived: 10-Q 6 month − 10-Q 3 month · filed 2021-08-06
-$2.10M
10-Q · filed 2021-08-06
$2.36M
derived: sum of 3 quarters · filed 2022-02-18
$3.84M
derived: sum of 4 quarters · filed 2022-02-18
2020-03-31$6.19M
10-Q · filed 2021-05-07
$10.64M
derived: sum of 2 quarters · filed 2022-02-18
$12.13M
derived: sum of 3 quarters · filed 2022-02-18
$11.45M
derived: sum of 4 quarters · filed 2022-02-18
2019-12-31$4.45M
derived: 10-K 12 month − 10-Q 9 month · filed 2022-02-18
$5.94M
derived: sum of 2 quarters · filed 2022-02-18
$5.25M
derived: sum of 3 quarters · filed 2022-02-18
$5.29M
10-K · filed 2022-02-18
2019-09-30$1.48M
derived: 10-Q 9 month − 10-Q 6 month · filed 2020-11-12
$800.00K
derived: sum of 2 quarters · filed 2020-11-12
$838.00K
10-Q · filed 2020-11-12
$3.64M
derived: sum of 4 quarters · filed 2021-02-26
2019-06-30-$683.00K
derived: 10-Q 6 month − 10-Q 3 month · filed 2020-08-12
-$645.00K
10-Q · filed 2020-08-12
$2.15M
derived: sum of 3 quarters · filed 2021-02-26
2019-03-31$38.00K
10-Q · filed 2020-05-12
$2.84M
derived: sum of 2 quarters · filed 2021-02-26
2018-12-31$2.80M
derived: 10-K 12 month − 10-Q 9 month · filed 2021-02-26
$2.60M
10-K · filed 2021-02-26
2018-09-30-$199.00K
10-Q · filed 2019-11-12
2017-12-31$3.50M
10-K · filed 2020-02-27